Executive Committee

Dr. Subhedar is a Consultant Neonatologist working at Liverpool Women’s Hospital, Honorary Lecturer at the University of Liverpool and Clinical Lead for the Cheshire & Merseyside Neonatal Network. His research interests include neonatal pulmonary hypertension, inhaled nitric oxide therapy, neonatal haemodynamics and echocardiography. He is a co-applicant on the UK multicentre NIHR-HTA funded Baby OSCAR trial into early selective treatment of patent ductus arteriosus. He led the first randomised controlled trial of inhaled nitric oxide in preterm neonates and previously chaired the European Inhaled Nitric Oxide Registry.

Patrick McNamara graduated from Queens University Belfast in 1987, received his MRCPCH in Pediatrics in 1997 and Certificate of Completion of Specialist Training in Neonatal Medicine in 2002. He is currently a Staff Neonatologist and Director of the Division of Neonatology at the University of Iowa Stead Family Children’s Hospital, and Professor of Pediatrics and Internal Medicine, University of Iowa.

He is the current chair of the PanAmerican Hemodynamic Collaborative, Pediatric Academic Society Neonatal Hemodynamics Advisory and Neonatal Hemodynamics (TnECHO) Special Interest Group at the American Society of Echocardiography. His clinical and research interests include myocardial performance in the settings of a hemodynamically significant ductus arteriosus, pulmonary hypertension and targeted neonatal echocardiography. He has published over 350 peer reviewed publications, chapters and other works.

Dr. Kara Goss is currently an Associate Professor of Medicine and Pediatrics at the University of Texas Southwestern Medical Center in Dallas, Texas. Trained in Internal Medicine, Pediatrics, and Adult Pulmonary and Critical Care including pulmonary hypertension and right ventricular failure, she has developed unique lifespan expertise in the long-term cardiopulmonary effects of preterm birth. Her overall research goal is to address the effect of preterm birth on the development of late cardiopulmonary sequelae, including pulmonary hypertension, lung disease, and impaired cardiopulmonary reserve.

Chris Gale is a Professor of Neonatal Medicine at Imperial College London and Consultant Neonatologist at Chelsea and Westminster Hospital. His research focuses on large, pragmatic neonatal trials and the use of routinely recorded data to improve neonatal care through observational studies and population surveillance. He has led development of a Core Outcome Set and other core data items in neonatology and other specialties.

Dr. Steven Abman is Professor of Pediatrics and Director of the Pediatric Heart Lung Center (PHLC) at the University of Colorado Denver Anschutz School of Medicine and Children’s Hospital Colorado.

Trained in Pediatric Pulmonary and Critical Care Medicine, Dr. Abman has maintained strong translational research and clinical interests in neonatal lung injury, lung vascular development, pulmonary hypertension, chronic lung disease in the newborn (bronchopulmonary dysplasia, BPD), pulmonary hypertension, and related topics. He has received uninterrupted NIH-funding for research and training grants throughout his academic career. Dr. Abman founded and was past Director the Pediatric Pulmonary Hypertension Network (PPHNet) and was one of the co-founders and is Vice-Chair of the BPD Collaborative. He is currently a co-leader of the Pulmonary Vascular Research Institute (PVRI) Pediatric Task Force. He recently completed his tenure as President of the American Pediatric Society.

His work has been recognized through several national awards as recipient of the Outstanding Investigator Award from the American Academy of Pediatrics (1998), the E. Mead Johnson Award of the SPR (1999), the Distinguished Achievement Award of the American Thoracic Society (2015), the Maureen Andrew Mentorship Award from the SPR (2015), the Mary Ellen Avery Award (2016) from the APS and SPR, and the Arvo Yllpo Medal Award from Finland (2017).